Top

BMC Infectious Diseases

Published in:

Open Access 01-12-2016 | Research article

Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses, and Treponema pallidum infections among blood donors at Shiyan, Central China

Authors: Shuguo Yang, Danmei Jiao, Changjun Liu, Ming Lv, Shan Li, Zongyun Chen, Yao Deng, Yanqing Zhao, Jian Li

Published in: BMC Infectious Diseases | Issue 1/2016

Abstract

Background

Ordinary screening of transfusion-transmissible infections (TTIs) among blood donors is essential for blood transfusion. Although there is several TTIs studies focus on human immunodeficiency virus, hepatitis B and C viruses, and Treponema pallidum infections in China, it is no data to illustrate any firm conclusion from Shiyan City, Central China. It aims to verify the seroprevalence of TTIs among blood donors at Shiyan.

Methods

A retrospective analysis of blood donors’ information was conducted for the presence of HIV, HBV, HCV and T. pallidum. Logistic regression analysis was used to demonstrate risk factors including age, gender and occupation associated with them. The variation tendency in seroprevalence of these TTIs over the study period was evaluated by Cochran-Armitage trend test.

Results

Of 211 639 blood donors, 2 858 (1.35 %) had serological evidence of TTIs. The seroprevalence of HIV, HBV, HCV and T. pallidum were 0.08 %, 0.51 %, 0.20 % and 0.57 %, respectively. However, the co-infection prevalence of TTIs has not been detected. The HIV seropositivity significantly increased among female donors (OR = 1.63, P < 0.001) and farmers (OR = 2.02, P = 0.020). Significantly increased HBV seropositivity was only observed framers (OR = 1.87, P <0.001) compared to workers. Analogously, significantly increased HCV seropositivity was observed among farmers (OR = 2.59, P < 0.001), students (OR = 2.43, P < 0.001), merchants (OR = 1.70, P = 0.014) and others (OR = 1.78, P =0.001). The T. pallidum seroprevalence was notably increased among female (OR = 1.54, P < 0.001), and farmers (OR = 1.70, P <0.001). Moreover, significantly increasing trends of HIV (Z = −6.88, P < 0.01), HBV (Z = −4.52, P < 0.01), HCV (Z = −4.16, P < 0.01) and T. pallidum (Z = −1.36, P < 0.01) seropositivity were observed over the study period.

Conclusions

It originally offers a substantial prevalence of TTIs among blood donors at Shiyan, Central China. Severe blood donor selection and all-inclusive screening of blood are highly recommended. It might be helpful for developing and updating guidance for blood safety.

Trial registration

Retrospectively registered.

Allain JP, Thomas I, Sauleda S. Nucleic acid testing for emerging viral infections. Transfus Med. 2002;12(4):275–83.CrossRefPubMed

Luban NL. Transfusion safety: Where are we today? Ann N Y Acad Sci. 2005;1054:325–41.CrossRefPubMed

Brown MR, Fritsma MG, Marques MB. Transfusion safety: what has been done; what is still needed? MLO Med Lab Obs. 2005;37(11):20. 22–23, 26.PubMed

Shan H, Wang JX, Ren FR, Zhang YZ, Zhao HY, Gao GJ, Ji Y, Ness PM. Blood banking in China. Lancet. 2002;360(9347):1770–5.CrossRefPubMed

Li C, Xiao X, Yin H, He M, Li J, Dai Y, Fu Y, Ge J, Yang Y, Luan Y, et al. Prevalence and prevalence trends of transfusion transmissible infections among blood donors at four Chinese regional blood centers between 2000 and 2010. J Transl Med. 2012;10:176.CrossRefPubMedPubMedCentral

Ji ZH, Li CY, Lv YG, Cao W, Chen YZ, Chen XP, Tian M, Li JH, An QX, Shao ZJ. The prevalence and trends of transfusion-transmissible infectious pathogens among first-time, voluntary blood donors in Xi'an, China between 1999 and 2009. Int J Infect Dis. 2013;17(4):e259–262.CrossRefPubMed

Dong R, Qiao X, Jia W, Wong M, Qian H, Zheng X, Xing W, Lai S, Wu Z, Jiang Y, et al. HIV, HCV, and HBV co-infections in a rural area of Shanxi province with a history of commercial blood donation. Biomed Environ Sci. 2011;24(3):207–13.PubMed

Song Y, Bian Y, Petzold M, Ung CO. Prevalence and trend of major transfusion-transmissible infections among blood donors in Western China, 2005 through 2010. PLoS One. 2014;9(4):e94528.CrossRefPubMedPubMedCentral

Yuan X, Wei S, Shu Q: Survey of clinical blood consumption from 2008 to 2010 in Shiyan City, Central China. Chinese Journal of Blood Transfusion 2012(05):479–480

10.

Li J, Chen J, Xie D, Monte-Nguba SM, Eyi JU, Matesa RA, Obono MM, Ehapo CS, Yang L, Lu D, et al. High prevalence of pfmdr1 N86Y and Y184F mutations in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea. Pathog Glob Health. 2014;108(7):339–43.CrossRefPubMedPubMedCentral

11.

Tessema B, Yismaw G, Kassu A, Amsalu A, Mulu A, Emmrich F, Sack U. Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: declining trends over a period of five years. BMC Infecti Dis. 2010;10:111.CrossRef

12.

Eboumbou Moukoko CE, Ngo Sack F, Essangui Same EG, Mbangue M, Lehman LG. HIV, HBV, HCV and T. pallidum infections among blood donors and Transfusion-related complications among recipients at the Laquintinie hospital in Douala, Cameroon. BMC Hematol. 2014;14(1):5.CrossRefPubMedPubMedCentral

13.

Buseri FI, Muhibi MA, Jeremiah ZA. Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria. Blood Transfus. 2009;7(4):293–9.PubMedPubMedCentral

14.

Zou S, Stramer SL, Dodd RY. Donor testing and risk: current prevalence, incidence, and residual risk of transfusion-transmissible agents in US allogeneic donations. Transfus Med Rev. 2012;26(2):119–28.CrossRefPubMed

15.

Uzun B, Gungor S, Demirci M. Seroprevalence of transfusion transmissible infections among blood donors in western part of Turkey: a six-year study. Transfus Apher Science. 2013;49(3):511–5.CrossRef

16.

Lieshout-Krikke RW, Zaaijer HL, van de Laar TJ. Predonation screening of candidate donors and prevention of window period donations. Transfusion. 2015;55(2):373–8.CrossRefPubMed

17.

Lu J, Xu J, Reilly KH, Li Y, Zhang CM, Jiang Y, Geng W, Wang L, Shang H. The proportion and trend of human immunodeficiency virus infections associated with men who have sex with men from Chinese voluntary blood donors: a systematic review and meta-analysis. Transfusion. 2015;55(3):576–85.CrossRefPubMed

18.

Sullivan PS, Hamouda O, Delpech V, Geduld JE, Prejean J, Semaille C, Kaldor J, Folch C, Op de Coul E, Marcus U, et al. Reemergence of the HIV epidemic among men who have sex with men in North America, Western Europe, and Australia 1996–2005. Ann Epidemiol. 2009;19(6):423–31.CrossRefPubMed

19.

Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992–2005 in China. J Infect Dis. 2009;200(1):39–47.CrossRefPubMed

20.

Garcia-Montalvo BM. Seropositivity of HIV, HBV, HCV and Treponema pallidum in blood donors in southeast Mexico. Rev Invest Clin. 2006;58(6):567–72.PubMed

21.

Shrestha AC, Ghimire P, Tiwari BR, Rajkarnikar M. Transfusion-transmissible infections among blood donors in Kathmandu, Nepal. J Infect Dev Ctries. 2009;3(10):794–7.CrossRefPubMed

22.

Mythreyee M, Jayachandran C, Amudhan M, Sivashankar M, Mythily N, Sekar R. Low prevalence of transfusion-transmissible infections among voluntary blood donors in South India. J Infect Dev Ctries. 2011;5(5):410–2.PubMed

23.

Umolu PI, Okoror LE, Orhue P. Human immunodeficiency virus (HIV) seropositivity and hepatitis B surface antigenemia (HBSAG) among blood donors in Benin city, Edo state, Nigeria. Afr Health Sci. 2005;5(1):55–8.PubMedPubMedCentral

24.

Diarra A, Kouriba B, Baby M, Murphy E, Lefrere JJ. HIV, HCV, HBV and syphilis rate of positive donations among blood donations in Mali: lower rates among volunteer blood donors. Transfus Clin Biol. 2009;16(5–6):444–7.CrossRefPubMed

25.

Averhoff FM, Glass N, Holtzman D. Global burden of hepatitis C: considerations for healthcare providers in the United States. Clin Infect Dis. 2012;55 Suppl 1:S10–15.CrossRefPubMed

26.

Sievert W, Altraif I, Razavi HA, Abdo A, Ahmed EA, Alomair A, Amarapurkar D, Chen CH, Dou X, El Khayat H, et al. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int. 2011;31 Suppl 2:61–80.CrossRefPubMed

27.

Wang J, Liu J, Huang Y, Wright DJ, Li J, Zhou Z, He W, Yang T, Yao F, Zhu X, et al. The persistence of hepatitis C virus transmission risk in China despite serologic screening of blood donations. Transfusion. 2013;53(10 Pt 2):2489–97.CrossRefPubMed

28.

Rivas P, Herrero MD, Poveda E, Madejon A, Trevino A, Gutierrez M, Ladron de Guevara C, Lago M, de Mendoza C, Soriano V, et al. Hepatitis B, C, and D and HIV infections among immigrants from Equatorial Guinea living in Spain. Am J Trop Med Hyg. 2013;88(4):789–94.CrossRefPubMedPubMedCentral

29.

Tucker JD, Chen XS, Peeling RW. Syphilis and social upheaval in China. N Engl J Med. 2010;362(18):1658–61.CrossRefPubMed

30.

Chen ZQ, Zhang GC, Gong XD, Lin C, Gao X, Liang GJ, Yue XL, Chen XS, Cohen MS. Syphilis in China: results of a national surveillance programme. Lancet. 2007;369(9556):132–8.CrossRefPubMed

31.

Pallavi P, Ganesh CK, Jayashree K, Manjunath GV. Seroprevalence and trends in transfusion transmitted infections among blood donors in a university hospital blood bank: a 5 year study. Indian J Hematol Blood Transfus. 2011;27(1):1–6.CrossRefPubMed

32.

Arora D, Arora B, Khetarpal A. Seroprevalence of HIV, HBV, HCV and syphilis in blood donors in Southern Haryana. Indian J Pathol Microbiol. 2010;53(2):308–9.CrossRefPubMed

33.

Chow EPF, Wilson DP, Zhang L. HIV and Syphilis Co-Infection Increasing among Men Who Have Sex with Men in China: A Systematic Review and Meta-Analysis. PLoS One. 2011;6(8):e22768.CrossRefPubMedPubMedCentral

34.

Stokx J, Gillet P, De Weggheleire A, Casas EC, Maendaenda R, Beulane AJ, Jani IV, Kidane S, Mosse CD, Jacobs J, et al. Seroprevalence of transfusion-transmissible infections and evaluation of the pre-donation screening performance at the Provincial Hospital of Tete, Mozambique. BMC Infect Dis. 2011;11:141.CrossRefPubMedPubMedCentral

35.

Nagalo BM, Bisseye C, Sanou M, Kienou K, Nebie YK, Kiba A, Dahourou H, Ouattara S, Nikiema JB, Moret R, et al. Seroprevalence and incidence of transfusion-transmitted infectious diseases among blood donors from regional blood transfusion centres in Burkina Faso, West Africa. Trop Med Int Health. 2012;17(2):247–53.CrossRefPubMed

36.

Lucky TT, Seed CR, Keller A, Lee J, McDonald A, Ismay S, Wand H, Wilson DP. Trends in transfusion-transmissible infections among Australian blood donors from 2005 to 2010. Transfusion. 2013;53(11):2751–62.CrossRefPubMed

37.

Mbanya D. Use of quality rapid diagnostic testing for safe blood transfusion in resource-limited settings. Clin Microbiol Infect. 2013;19(5):416–21.CrossRefPubMed

38.

Ly TD, Laperche S, Brennan C, Vallari A, Ebel A, Hunt J, Martin L, Daghfal D, Schochetman G, Devare S. Evaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assays. J Virol Methods. 2004;122(2):185–94.CrossRefPubMed

39.

Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, Hase T. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000;28(12):E63.CrossRefPubMedPubMedCentral

Title: Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses, and Treponema pallidum infections among blood donors at Shiyan, Central China
Authors: Shuguo Yang
Danmei Jiao
Changjun Liu
Ming Lv
Shan Li
Zongyun Chen
Yao Deng
Yanqing Zhao
Jian Li
Publication date: 01-12-2016
Publisher: BioMed Central
Published in: BMC Infectious Diseases / Issue 1/2016
Electronic ISSN: 1471-2334
DOI: https://doi.org/10.1186/s12879-016-1845-z

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses, and Treponema pallidum infections among blood donors at Shiyan, Central China

Abstract

Background

Methods

Results

Conclusions

Trial registration

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2016

Tuberculous meningitis is a major cause of mortality and morbidity in adults with central nervous system infections in Kota Kinabalu, Sabah, Malaysia: an observational study

Outcome of patients with streptococcal prosthetic joint infections with special reference to rifampicin combinations

A cross-sectional study on the concordance between vaginal HPV DNA detection and type-specific antibodies in a multi-ethnic cohort of women from Amsterdam, the Netherlands – the HELIUS study

The Respiratory Protection Effectiveness Clinical Trial (ResPECT): a cluster-randomized comparison of respirator and medical mask effectiveness against respiratory infections in healthcare personnel

Accuracy of clinical criteria and an immunochromatographic strip test for dengue diagnosis in a DENV-4 epidemic

Oral fosfomycin for treatment of urinary tract infection: a retrospective cohort study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page